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• BALC patient post-surgical survival period was greater than the 
“Mixed” group one.
Discussion: The characterization of the BALC as a separate entity with 
particular characteristics appears to have practical and objective effects 
in the determination of this disease’s prognosis. This population sample 
analysis seems to verify the importance of this new classiﬁcation. Fu-
ture analysis with larger samples and for longer follow-up periods may 
further support these data.
P1-176 Pathology Posters, Mon, Sept 3 
Effects of vascular endothelial growth factors (VEGFs) on 
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Background: The expression of vascular endothelial growth factors 
(VEGFs) in tumors including lung cancer is considered to be associ-
ated with tumor development via angiogenesis and lymphangiogenesis. 
Pleural dissemination and lymph node metastasis of lung cancer are 
major poor prognostic factors. We investigate how VEGF-A, VEGF-C, 
and VEGF-D expressed in the intrathoracic inﬁltrating lung cancer cells 
are involved in dissemination and metastasis. 
Methods: We established large cell lung cancer cell lines in which 
stably VEGF-A-, VEGF-C-, VEGF-D-, or VEGF-C and VEGF-D were 
stably expressed (TKB5/VEGF-A, TKB5/VEGF-C, TKB5/VEGF-D, 
TKB5/VEGF-C/D, respectively). These transfectants were orthotopi-
cally inoculated into the right thoracic cavity (i.t.) of nude mice, and 
then we evaluated subsequent development of pleural effusion, pleural 
dissemination, and lymph node metastasis. 
Results: There were no signiﬁcant differences in cell growth rate 
among the control lines (empty vector-transfected TKB5) and VEGF-
transfectants in vitro. However, each i.t. model demonstrated signiﬁ-
cantly different biological properties. TKB5/empty showed no apparent 
pleural effusion, dissemination, or lymph node metastasis. In contrast, 
TKB5/VEGF-A, TKB5/VEGF-C, TKB5/VEGF-D, and TKB5/VEGF-
C/D promoted bloody pleural effusion and dissemination (4/4, 4/7, 4/4, 
and 5/10, respectively). TKB5/VEGF-D and TKB5/VEGF-C/D showed 
aggressive mediastinal invasion around the thoracic aorta and thoracic 
duct. Furthermore, TKB5/VEGF-C/D generated mediastinal lymph 
node metastasis (2/10). These ﬁndings suggested that VEGF-D could 
facilitate mediastinal spread of lung cancer cells. Immunohistochemi-
cal study revealed that the expression of both VEGF-A and VEGF-D in 
the disseminated tumor promoted intense blood vessel formation rather 
than lymph vessel formation. In contrast, TKB5/VEGF-C showed mild 
increase of lymph vessel density and signiﬁcantly low blood vessel 
density in the disseminated tumor. 
Conclusions: The biological behavior of lung cancer cells within 
the thoracic cavity appears to be regulated by expression patterns of 
VEGFs. The regulation of the expression of VEGFs in intrathoracic 
lung cancer cells might be a useful therapeutic approach to inhibit 
tumor development and improve patient prognosis. 
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The cytopathologic diagnoses of fine needle aspirations from 
endoscopic ultrasound of the mediastinum:Reproducibility of the 
diagnoses and representativeness of aspirates from lymph nodes.
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Background: Endoscopic ultrasound guided ﬁne needle aspiration 
biopsy through the oesophagus (EUS-FNA) or the bronchial tree 
(Endobronchial ultrasound guided transbronchial needle aspiration 
(EBUS-TBNA)) may be used to obtain specimens from mediastinal 
structures. However, no studies have studied the reproducibility of the 
pathological assessment of the aspirated material. 
Methods: 102 slides from EUS-FNA or EBUS-TBNA were assessed 
two times by four pathologists who classiﬁed each slide to one of ﬁve 
diagnostic categories, and judged if the aspirate came from a lymph 
node. Between the two rounds, the criteria to be used in the assessment 
of the slides were reviewed in a limited education session.
The four observers had at least 15 years of pathology experience, but 
their experience in EUS-FNA and/or EBUS TBNA varied from almost 
none to more than 20 years. The Kappa statistic was applied for the 
analysis of reproducibility.
Results: The reproducibility of the diagnoses in the ﬁrst round was 
good to excellent (Kappa 0.52-0.89). The teaching session led to a 
signiﬁcant improvement of the reproducibility between the least and 
the most experienced observers (Kappa ranges of 0.52-0.55 in the ﬁrst 
round improved to 0.65-0.71 in the second round). 
Conclusion: The reproducibility of the diagnosis on EBUS-TBNA and 
EUS-FNA is excellent among pathologists experienced with this type of 
samples. Pathologists who are generally experienced but have little ex-
perience with EBUS-TBNA and EUS-FNA show a steep learning curve. 
From a pathologic point of view, EBUS-TBNA and EUS-FNA are 
feasible, but only experienced pathologists should do the assessments. 
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A case with two different primary lung tumor which had different mor-
phologic and immunophenotypic features and associated multisystemic 
MALT type extranodal (lung, stomach, duodenum) marginal zone 
lymphoma is reported.
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Coexistence of MALT lymphoma with carcinomas was seen primarly 
in gastric lesions associated with H. Pylori infections. To our knowl-
edge only one case was reported with synchronous pulmonary adeno-
carcinoma and MALT type extranodal marginal zone lymphoma.
Case Report: A 49 years old male presented with back pain, weight 
loss and fatique. Chest x-ray revealed an increased density suggest-
ing a mass localized to superior zone of left lung. Systemic radiologic 
examination of the patient did not reveal any other mass lesion. Endo-
scopic examination of upper gastrointestinal system revealed gastric 
ulcer. The biopsy taken from the stomach and duodenum showed 
MALT lymphoma in both locations. He underwent an exploratory chest 
operation, during which a mass lesion comletely invading thorasic 
outlet and a second mass lesion located in apical segment of left upper 
lobe, seperated from the ﬁrst mass by a thickened pleura were noted. A 
frozen section diagnoses of malignant neoplasm was given for the mass 
lesion invading thorasic outlet. Therefore, this mass was exsized along 
with wedge resection of the second apical lung lesion. The exsized ﬁrst 
mass measured 5x4x0,7 cm, it was hard and gray to brown colored. 
The wedge resection covered with visceral pleura measured 8x5,5x 
2cm and contained an inﬁltrative hard, grayish white mass of 2 cm 
diameter without pleural involvement.These two tumors,one of which 
was primarily localized in pleura with limited extension into the lung 
parenchyma and the other mainly localized in the lung parenchyma 
had different morphologic and immune phenotypic features. Light 
microscopy of the tumor involving mainly pleura showed a malignant 
epithelial tumor with mainly diffuse patern with focal papillary areas. 
The differential diagnoses of this tumor included primary or metastatic 
adenocarcinoma and epithelial mesothelioma. Mucicarmine stain was 
negative while PAS and D-PAS stains were positive in some tumor 
cells. Tumor cells were pankeratin and vimentin positive, TTF-1, CK7, 
CK 5/6, CK20, CEA, calretinin, NSE, synaptophysin and chromogranin 
negative. There was focal CD15 positivity. Although CK7 and TTF-1 
were negative, these morphologic, histochemical and immunohisto-
chemical features suggested that this tumor might represent an undiffer-
entiated large cell or poorly differentiated pulmonary adenocarcinoma. 
The second tumor localized in lung parenchyma was well differentiated 
adenocarcinoma with mucicarmine positive intracytoplasmic mucine 
secretion. It had CK7, TTF-1 positive and vimentin, CK 5/6 and CK20 
negative immunophenotype. This tumor was intimately associated with 
diffuse neoplastic lymphocytic inﬁltration. Neoplastic lymphocytic 
cells had a monocytoid appearance with formation of occasional lym-
phoepithelial lesions. Lymphocytic tumor cells CD20 positive, CD5, 
CD10, CD23, CD3 and cyclinD1 negative immunophenotype. Because 
of these features, a diagnoses of MALT lymphoma was given. 
To the best of our knowledge our case is the ﬁrst one that presented 
with two different lung carcinomas which had different morphologic 
and immunophenotypic features, one of which was associated with 
multisystemic (lung, stomach,duodenum) extranodal marginal zone 
lymphoma of MALT type.
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Clinicopathological study of bronchogenic carcinoma - a study of 
303 cases
Uddin, Mokhles 
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Subjects: 303 patients of bronchogenic carcinoma in the Department 
of Radiotherapy. Dhaka Medical College Hospital. Dhaka from 1st 
January 2000 to 31st December 2005. 
Settings: Department of Radiotherapy, Dhaka Medical College Hospital
Main Outcome Measures: This study reveals a general idea of certain 
clinicopathological aspects of bornchogenic carcinoma prevailing 
amongst the population of Bangladesh.
Results: Males (87.79%) suffered more than females (12.2%) their 
ratio was 7.19:1. Majority of the patients were of elderly age group 
with peak occurrence between 50 and 59 years. More than 90% of the 
patients were smoker. 86.47% chewed betel leaf 68.65% used tea and 
only 19 (6.27%) were alcoholic. More than 60% of the patients were 
lower socioeconomic class and others from middle class family. Ap-
proximately 40% of the patients were illiterate. 37.29% had primary 
education. 12.54% secondary school education. 5.96% higher second-
ary and only 4.62% graduate and above.
Cough (77.89%) was the commonest presenting symptom followed 
by chest pain (66%). Dyspnoea (44.55%). haemoptysis {40.59%}. 
Squamous cell carcinoma (51.82%) was the most common histology 
followed by small cell carcinoma (19.14%). adenocarcinoma (13.86%). 
large cell carcinoma (7.28%). Right lung was effective more and the 
upper lobes were the common sites of involvement.
Conclusion: This study correlates and sometimes differs with the data 
of studies at home and abroad. But reﬂects at least some clinical and 
pathological aspects of bronchial carcinoma in Bangladesh.
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Background: The human epidermal growth factor receptor (HER) 
family of receptor tyrosine kinase has been demonstrated to be overex-
pressed in the majority of NSCLC, leading to the clinical development 
of molecular therapies targeting the epidermal growth factor receptor 
(EGFR). Among the various small molecule inhibitors of tyrosine ki-
nase, geﬁtinib has been approved for clinical use in patients with previ-
ously treated advanced NSCLC. It has shown dramatic effectiveness 
in certain patient subsets, including women, never-smokers, adeno-
carcinomas, and East Asian descents. However, predictive molecular 
markers are yet to be determined. 
Design: EGFR protein overexpression by immunohistochemistry and 
gene ampliﬁcation by chromogenic in situ hybridization (CISH) were 
analyzed in biopsy specimens from 46 patients with advanced NSCLC. 
After failure of ﬁrst-line treatment, 29 had received geﬁtinib. Time 
to progression (TTP) and overall survival (OS) were correlated with 
EGFR status.
